Fertility and Sterility
Volume 88, Issue 4 , Pages 900-905 , October 2007

Lack of association between polycystic ovary syndrome and embryonic aneuploidy

  • Andrea Weghofer, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut
    • Department of Obstetrics and Gynecology, Medical University Vienna, Vienna, Austria
    • Corresponding Author InformationReprint requests: Andrea Weghofer, M.D., Ph.D., Department of Obstetrics and Gynecology, Medical University Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria (FAX: 431404002861).
    • ,
  • Santiago Munne, Ph.D.

      Affiliations

    • Reprogenetics, LLC, West Orange, New Jersey
    • ,
  • Serena Chen, M.D.

      Affiliations

    • The Institute for Reproductive Medicine and Science, Saint Barnabas Medical Center, Livingston, New Jersey
    • ,
  • David Barad, M.D., M.Sc.

      Affiliations

    • The Center for Human Reproduction,New York, New York
    • ,
  • Norbert Gleicher, M.D.

      Affiliations

    • Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut
    • The Center for Human Reproduction,New York, New York

Received 28 June 2006 ,Revised 22 December 2006 ,Accepted 22 December 2006.

References 

  1. Balen A. The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology. Best Pract Res Clin Obstet Gynaecol. 2004;18:685–706
  2. Homburg R. The management of infertility associated with polycystic ovary syndrome. Reprod Biol Endocrinol. 2003;1:109–117
  3. Barnes FL, Kausche A, Tiglias J, Wood C, Wilton L, Trounson A. Production of embryos from in vitro-matured primary human oocytes. Fertil Steril. 1996;65:1151–1156
  4. Kovacs G, Wood C. The current status of polycystic ovary syndrome. Aust NZ J Obstet Gynaecol. 2001;41:65–68
  5. Kodama H, Fukuda J, Karube H, Matsui T, Shimizu Y, Tanaka T. High incidence of embryo transfer cancellations in patients with polycystic ovarian syndrome. Hum Reprod. 1995;10:1962–1967
  6. Ludwig M, Finas DF, al-Hasani S, Diedrich K, Ortmann O. Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients. Hum Reprod. 1999;14:354–358
  7. Munne S, Alikani M, Tomkin G, Grifo J, Cohen J. Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities. Fertil Steril. 1995;64:382–391
  8. Gianaroli L, Magli MC, Ferraretti AP, Lappi M, Borghi E, Ermini B. Oocyte euploidy, pronuclear zygote morphology and embryo chromosomal complement. Hum Reprod. 2007;22:241–249
  9. Gianaroli L, Magli MC, Ferraretti AP, Fortini D, Grieco N. Pronuclear morphology and chromosomal abnormalities as scoring criteria for embryo selection. Fertil Steril. 2003;80:341–349
  10. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group . Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–47
  11. Velilla E, Escudero T, Munne S. Blastomere fixation techniques and risk of misdiagnosis for preimplantation genetic diagnosis of aneuploidy. Reprod Biomed Online. 2002;4:210–217
  12. Munne S, Marquez C, Magli C, Morton P, Morrison L. Scoring criteria for preimplantation genetic diagnosis of numerical abnormalities for chromosomes X, Y, 13, 16, 18 and 21. Mol Hum Reprod. 1998;4:863–870
  13. Munne S, Sandalinas M, Magli C, Gianaroli L, Cohen J, Warburton D. Increased rate of aneuploid embryos in young women with previous aneuploid conceptions. Prenat Diagn. 2004;24:638–647
  14. Colls P, Sandalinas M, Pagidas K, Munne S. PGD analysis for aneuploidy in a patient heterozygous for a polymorphism of chromosome16(16qh-). Prenat Diagn. 2004;24:741–744
  15. Munne S, Bahce M, Sandalinas M, Escudero T, Marquez C, Velilla E, et al. Differences in chromosome susceptibility to aneuploidy and survival to first trimester. Reprod Biomed Online. 2004;8:81–90
  16. Nikolaou D, Templeton A. Early ovarian aging: a hypothesis. Hum Reprod. 2003;18:1137–1139
  17. Fiddelers AA, van Montfoort AP, Dirksen CD, Dumoulin JC, Land JA, Dunselman GA, et al. Single versus double embryo transfer: cost-effectiveness analysis alongside a randomized clinical trial. Hum Reprod. 2006;21:2090–2097
  18. Papanikolaou EG, Camus M, Kolibianakis EM, Van Landuyt L, Van Steirteghem A, Devroey P. In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos. N Engl J Med. 2006;16(354):1139–1146
  19. Sharma V, Allgar V, Rajkhowa M. Factors influencing the cumulative conception rate and discontinuation of in vitro fertilization treatment for infertility. Fertil Steril. 2002;78:40–46
  20. Veleva Z, Jarvela IY, Nuojua-Huttunen S, Martikainen H, Tapanainen JS. An initial low response predicts poor outcome in in vitro fertilization/ intracytoplasmic sperm injection despite improved ovarian response in consecutive cycles. Fertil Steril. 2005;83:1384–1390
  21. Jabara S, Coutifaris C. In vitro fertilization in the PCOS patient: clinical considerations. Semin Reprod Med. 2003;21:317–324
  22. Bahceci M, Ulug U, Ben-Shlomo I, Erden HF, Akman MA. Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study. J Reprod Med. 2005;50:84–90
  23. Sengoku K, Tamate K, Takuma N, Yoshida T, Goishi K, Ishikawa M. The chromosomal normality of unfertilized oocytes from patients with polycystic ovarian syndrome. Hum Reprod. 1997;12:474–477
  24. Hansmann I, Jenderny J, Probeck HD. Low doses of X-rays decrease the risk of diploidy in mouse oocytes. Mutat Res. 1983;109:99–110
  25. Pellicer A, Valbuena D, Cano F, Remohi J, Simon C. Lower implantation rates in high responders: evidence for an altered endocrine milieu during the preimplantation period. Fertil Steril. 1996;65:1190–1195
  26. Cermik D, Selam B, Taylor HS. Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88:238–243
  27. Druckmann R, Rohr UD. IGF-1 in gynaecology and obstetrics: update 2002. Maturitas. 2002;41(Suppl 1):S65–S83
  28. Tuckerman EM, Okon MA, Li T, Laird SM. Do androgens have a direct effect on endometrial function? An in vitro study. Fertil Steril. 2000;74:771–779
  29. Apparao KB, Lovely LP, Gui Y, Lininger RA, Lessey BA. Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biol Reprod. 2002;66:297–304
  30. Maliqueo M, Clementi M, Gabler F, Johnson MC, Palomino A, Sir-Petermann T, et al. Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome. Fertil Steril. 2003;80(Suppl 2):812–819
  31. van Gelderen CJ, Gomes dos Santos ML. Polycystic ovarian syndrome. Evidence for an autoimmune mechanism in some cases. J Reprod Med. 1993;38:381–386

PII: S0015-0282(07)00044-1

doi: 10.1016/j.fertnstert.2006.12.018

Fertility and Sterility
Volume 88, Issue 4 , Pages 900-905 , October 2007

Article Tools